Teva Pharmaceutical Industries Limited's latest marketcap:
As of 07/04/2025, Teva Pharmaceutical Industries Limited's market capitalization has reached $19.51 B. According to our data, Teva Pharmaceutical Industries Limited is the 1101th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 19.51 B |
| Revenue (ttm) | 16.62 B |
| Net Income (ttm) | -1,286,000,000 |
| Shares Out | 1.15 B |
| EPS (ttm) | -1.14 |
| Forward PE | 6.61 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/30/2025 |
Teva Pharmaceutical Industries Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | $19.51 B | -23.57% | 1101 |
| 12/31/2024 | $24.97 B | 113.39% | 768 |
| 12/29/2023 | $11.7 B | 15.54% | 1417 |
| 12/30/2022 | $10.13 B | 14.65% | 1496 |
| 12/31/2021 | $8.84 B | -16.46% | 2003 |
| 12/31/2020 | $10.58 B | -1.18% | 1555 |
| 12/31/2019 | $10.7 B | -31.87% | 1250 |
| 12/31/2018 | $15.71 B | -18.33% | 731 |
| 12/29/2017 | $19.23 B | -41.54% | 689 |
| 12/30/2016 | $32.9 B | -41.16% | 300 |
Company Profile
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited is a global leader in the development, manufacturing, and distribution of generic medicines, biopharmaceutical products, and active pharmaceutical ingredients. Headquartered in Tel Aviv, Israel, the company operates across the United States, Europe, and international markets.
Key Offerings
- Generic Medicines: Available in tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams.
- Specialty Products: Sterile formulations, hormones, high-potency drugs, and cytotoxic substances.
- Therapeutic Focus: Central nervous system (CNS), respiratory, and oncology treatments.
- Contract Manufacturing: Provides API production and out-licensing services for pharmaceutical companies.
Notable Products
- BENDEKA & TREANDA: For chronic lymphocytic leukemia and non-Hodgkin’s lymphoma.
- COPAXONE: Treats relapsing forms of multiple sclerosis.
- AJOVY: Preventive migraine treatment for adults.
- AUSTEDO: Addresses Huntington’s disease and tardive dyskinesia.
- UZEDY: Schizophrenia treatment.
- Respiratory Solutions: ProAir RespiClick, QVAR RediHaler, BRALTUS, and AirDuo RespiClick.
Over-the-Counter (OTC) Brands
- SUDOCREM
- NasenDuo
- DICLOX FORTE
- OLFEN Max
- FLEGAMINA
Strategic Collaborations
Teva partners with industry leaders including MedinCell S.A., Sanofi, Alvotech, Biolojic Design Ltd., and MODAG GmbH to enhance innovation and expand its product portfolio.
Founded: 1901 | Headquarters: Tel Aviv, Israel
Frequently Asked Questions
-
What is Teva Pharmaceutical Industries Limited's (TEVA) current market cap?As of 07/04/2025, Teva Pharmaceutical Industries Limited (including the parent company, if applicable) has an estimated market capitalization of $19.51 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Teva Pharmaceutical Industries Limited (TEVA) rank globally by market cap?Teva Pharmaceutical Industries Limited global market capitalization ranking is approximately 1101 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.